World
Oxford jab offers less S Africa variant protection
BBC
February 8, 2021 6:29 am
Oxford-AstraZeneca’s vaccine offers “minimal protection” against mild disease from the South Africa variant, scientists say early trials suggest.
A new study, not yet peer reviewed, involved about 2,000 people who were on average 31 years old.
But Prof Sarah Gilbert, Oxford lead vaccine developer, said vaccines should still protect against severe disease.
Article continues after advertisement
She said developers were likely to have a modified Oxford jab by the autumn to combat the South Africa variant.
Meanwhile, vaccine minister Nadhim Zahawi told the BBC’s Andrew Marr that a booster in the autumn and annual vaccines could be required to combat variants.
More than 100 cases of the South Africa variant have been found in the UK.
Sponsored Links
Claim Your Money Today!
Please click here to check and inform us at [email protected] to help us settle. Check List
By LICI
Extra Weekly Specials
Don't miss out on the amazing specials on offer this week at all Extra branches. Click Here to View
By Extra Supermarket
